Theralase Technologies Inc. (CVE:TLT)

PRESS RELEASE

published on 10/05/2023 at 13:00, 2 years 5 months ago

Theralase(R) Files US Patent for Enhanced Immunotherapy
PRESS RELEASE

published on 09/29/2023 at 13:00, 2 years 5 months ago

Theralase(R) Demonstrates 8 Year Shelf Life of Lead Drug Ruvidar(TM)
PRESS RELEASE

published on 09/27/2023 at 13:00, 2 years 5 months ago

Theralase(R) Successfully Completes Non-GLP Toxicity Analysis for Brain Cancer
PRESS RELEASE

published on 09/21/2023 at 22:35, 2 years 5 months ago

Theralase(R) Grants Stock Options
PRESS RELEASE

published on 09/07/2023 at 10:30, 2 years 6 months ago

Theralase(R) Closes Private Placement Equity Financing
PRESS RELEASE

published on 08/29/2023 at 22:30, 2 years 6 months ago

Theralase Release’s 2Q2023 Interim Financial Statements
PRESS RELEASE

published on 06/30/2023 at 22:35, 2 years 8 months ago

Theralase(R) Closes Non-Brokered Private Placement Equity Financing
PRESS RELEASE

published on 06/06/2023 at 13:00, 2 years 9 months ago

Theralase(R) Announces Appointment of New Independent Director
PRESS RELEASE

published on 05/31/2023 at 03:30, 2 years 9 months ago

Theralase(R) Releases Corrected and Restated Press Release for 1Q2023 Interim Financial Statements
PRESS RELEASE

published on 05/31/2023 at 01:35, 2 years 9 months ago

Theralase(R) Releases 1Q2023 Interim Financial Statements

Published on 03/19/2026 at 23:48, 2 hours 17 minutes ago

EQS-Adhoc: Dexus Finance Pty Limited: Appendix 3C daily buy back notice
Published on 03/19/2026 at 22:55, 3 hours 10 minutes ago

Baristas behind millions of cups of coffee compete globally
Published on 03/19/2026 at 22:48, 3 hours 17 minutes ago

EQS-Adhoc: Forecast for the 2026 financial year
Published on 03/19/2026 at 19:30, 6 hours 35 minutes ago

EEII AG: Publication of Listing Prospectus
Published on 03/19/2026 at 19:24, 6 hours 41 minutes ago

Fuller, Smith & Turner PLC: Transaction in own shares

News